Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs11060817 | chr12:130787732 | C/T | 3.93E-7 | 178 | 3.17 | 20.13 | 27.3 | KM Plot |
PCPG | rs11061226 | chr12:131385816 | G/A | 1.85E-7 | 172 | 24.62 | 25.4 | 19.87 | KM Plot |
PCPG | rs11063454 | chr12:5111535 | A/G | 3.08E-5 | 178 | 25.4 | 24.23 | 14.4 | KM Plot |
PCPG | rs11063463 | chr12:5121357 | G/A | 3.06E-5 | 176 | 25.53 | 24.1 | 14.4 | KM Plot |
PCPG | rs11066852 | chr12:114395549 | G/A | 9.14E-6 | 175 | 25.7 | 24.47 | 25.17 | KM Plot |
PCPG | rs11070206 | chr15:39753991 | T/G | 0.000433 | 177 | 24.85 | 27.27 | 26.33 | KM Plot |
PCPG | rs11076605 | chr16:89579123 | G/A | 0.000207 | 176 | 26.78 | 25.28 | 19.53 | KM Plot |
PCPG | rs11076606 | chr16:89585627 | A/G | 0.000238 | 177 | 26.78 | 25.53 | 19.3 | KM Plot |
PCPG | rs11076619 | chr16:89831243 | C/A | 0.000167 | 177 | 25.87 | 20.17 | 36.37 | KM Plot |
PCPG | rs11076620 | chr16:89831520 | A/T | 0.000167 | 177 | 25.87 | 20.17 | 36.37 | KM Plot |
PCPG | rs11076621 | chr16:89837927 | A/G | 0.000168 | 177 | 25.87 | 20.2 | 36.37 | KM Plot |
PCPG | rs11076622 | chr16:89837951 | T/C | 0.000168 | 177 | 25.87 | 20.2 | 36.37 | KM Plot |
PCPG | rs11076623 | chr16:89844120 | G/T | 0.000168 | 177 | 25.87 | 20.2 | 36.37 | KM Plot |
PCPG | rs11076624 | chr16:89855749 | T/C | 0.000159 | 177 | 25.87 | 20.37 | 36.37 | KM Plot |
PCPG | rs11076653 | chr16:90074001 | C/T | 8.43E-9 | 176 | 25.87 | 20.37 | 6.62 | KM Plot |